4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-068014
General Counsel and Secretary acquired 7,342 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2021-12-02 | Option exercise | +7,342 | $13.62 | $99,998 | 36,512 | D |
| Derivatives | |||||||
| KASINGER JAMES R. General Counsel and Secretary | 2021-12-02 | Option exercise · Stock Option (Right to Buy) | −7,342 | 93,632 | D | ||
Loading xslF345X03/doc4.xml…